NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device

NESHER, Israel - Portable Solution for Wound Healing Using Low Frequency, Low Intensity Ultrasound

Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries

CLEVELAND, Ohio - Simbionix, the world’s leading developer of medical simulation systems, today announced an agreement with Johnson & Johnson LLC for distribution of Simbionix’s simulators and related products.

Saebo United Kingdom Posts Record 2008; Sees Continued Growth in UK for 2009

CHARLOTTE, North Carolina - National Health Service hospitals’ usage by stroke rehab patients dictates increase in staff and Saebo-trained therapists

Kiadis Pharma Reports ATIR(TM) Clinical Data, Further Supporting its Potential in Mismatched Bone Marrow Transplantations

AMSTERDAM - ATIR(TM) Data Presented at the Annual EBMT Presidential Symposium

Biopharmaceutical company Kiadis Pharma reported preliminary clinical data on ATIR(TM) showing its potential in mismatched bone marrow transplantations. Data was presented by the company’s principal investigator Dr. Denis Claude Roy during the prestigious Presidential Symposium at the Annual European Bone Marrow Transplantation meeting (EBMT) in Goteborg, Sweden, on Monday, March 30, 2009. Only the 6 highest ranked presentations, representing the most promising new developments in the transplantation field, were selected for this Symposium.

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

ANN ARBOR, Michigan - Sustained Benefits for Patients Awaiting Transplantation

The DuraHeart(TM) Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were eligible for transplantation. These conclusions, based on the European experience with DuraHeart, the first active magnetically levitated centrifugal left ventricular assist system, are published on line in the European Journal of Cardio-thoracic Surgery (EJCTS) at dx.doi.org/10.1016/j.ejcts.2008.12.033.

RAPS Offers New International Regulatory Affairs Certification - RAC (GS)

ROCKVILLE, Maryland - New RAC Credential Focuses on General Scope of Regulatory Practice, International Standards

First Patients Enrolled in the Access-Europe Study of The MitraClip(R) Therapy

MENLO PARK, California - European Post Market Observational Study Intended to Collect Data to Demonstrate the Clinical and Health Economic Benefits of the MitraClip(R) Therapy for Patients with Mitral Regurgitation

Gerresheimer Achieves Solid Growth in Core Markets - Outlook Confirmed

DUSSELDORF, Germany - Group Sales in the First Quarter of 2009 at Prior Year Level; Sales up Almost 3% in the Core Business Despite Difficult Market Environment

Frost & Sullivan Applauds SHL Telemedicine for Excellence in Product Innovation

LONDON - The ‘2008 European Telemedicine Systems for Cardiac Monitoring Product Innovation of the Year Award’ is presented to SHL Telemedicine Ltd. in recognition of its next generation personal ECG device - the CardioSen’C(TM). This full 12 lead ECG personal digital cellular transmitter is a monitoring system that uses either cellular network (GPRS) or public switched telephone network (PSTN) to transmit real-time medical cardiological data remotely. It effectively fulfils the need for an end-user friendly system.

Expanding Patient Population Creates a Huge Market for Invasive Pressure Monitoring and Hemodynamic Monitoring, Finds Frost & Sullivan

LONDON - The higher incidence of chronic illnesses in Europe and the consequent
increase of patient population in intensive care units has amplified the need
for equipment that measure vital signs such as blood pressure during
surgeries. This rise in the number of people requiring critical care has
escalated the demand for catheters and transducers.

MitraClip(R) Therapy Data Shows Important Clinical Benefit in High Risk Patients With Functional Mitral Regurgitation at 12-Month Follow Up

ORLANDO, Florida - EVEREST High-Risk Registry Data Shows Improved Symptomatic Status and
Cardiac Function in Functional MR Patients Treated with the MitraClip(R)
System

US Patent Office Rejects 95% of Verathon Claims in Patent Case With Aircraft Medical

EDINBURGH, Scotland - On March 23, 2009 the United States Patent and Trademark
Office (”USPTO”) issued a Non-Final Action Closing Prosecution in the ongoing
re-examination of Verathon, Inc.’s United States Patent Number 6,543,447.
Aircraft Medical, Ltd. filed the request for the re-examination of this
patent in 2006 following litigation (currently on hold) that Verathon
initiated against Aircraft.

Health Robotics Announces the Early Release of the i.v.STATION(TM) Profile Option and DUPHAT Presentation

BOZEN, Italy - Health Robotics today announced the early release in the second half of
2009 of its i.v.STATION Profile option with a presentation [P13] at the Dubai
International Pharmaceuticals and Technologies Conference and Exhibition
(DUPHAT) www.duphat.ae/parallelSession.php on March 31, 2009 by Gaspar
DeViedma, along with related booth exhibitions.

New ZigBee Health Care Profile: Helping People Live Healthier and Independent Lives

BARCELONA, Spain - New standard provides a flexible framework to meet Continua Health
Alliance requirements for remote health and fitness monitoring

Dr. Thomas Werner Elected to Accera, Inc.’s Board of Directors

BROOMFIELD, Colorado - Accera, Inc., a biotechnology company delivering breakthrough therapies
in central nervous system (CNS) diseases, announced today that Thomas Werner,
Ph.D. has been elected to its board of directors.

Frost & Sullivan Commends Nycomed for Excellence in Product Differentiation Innovation

LONDON - The “2008 European Tissue Sealants & Topical Hemostats Product
Differentiation Innovation Award” is conferred on Nycomed in recognition of
its revolutionary product - TachoSil. The innovative surgical patch, TachoSil
is poised to be the future of the European tissue sealants and topical
hemostats markets.

Frost & Sullivan Recognises FUJIFILM Corporation’s Outstanding Product Quality Leadership

LONDON - The “2009 European Mammography Systems Product Quality Leadership Award”
is presented to FUJIFILM Corporation in recognition of the exceptional
quality of its Computed Radiography (CR) mammography systems. The company’s
superior quality control, product performance, quality assurance programme
and product manufacturing are also commended.

Relsys International Announces the Release of the Argus Safety(TM) Suite 5.0

IRVINE, California - Relsys International today announced the release of the Argus Safety
Suite 5.0, the new standard in global Drug Safety & Risk Management systems.
The Argus Safety Suite 5.0 is a full stack release.

U.S. Food and Drug Administration Clears Way for Multi-Center Clinical Trial of IDEV Technologies’ SUPERA Peripheral Stent

HOUSTON - Novel Stent Platform Designed for Radial Strength, Flexibility

IDEV Technologies Incorporated, (IDEV) an emerging leader in the
development and marketing of minimally invasive technologies, announced today
that the U.S. Food and Drug Administration (FDA) has approved an
investigational device exemption (IDE) for a multi-center clinical trial of
its SUPERA stent, a novel stent platform designed for the treatment of
peripheral artery disease (PAD) in the superficial femoral artery (SFA). PAD
affects more than 8 million people in the U.S. alone and, by the age of 65,
12-20 percent of the population will develop PAD, according to the American
Heart Association.

Ipsogen Announces the CE Marking of its “ProfileQuant(R) WT1″ Kit

MARSEILLE, France - WT1 is a Valuable Biomarker in the Prognosis and Follow-up
of Acute Myeloid Leukemia (AML) Patients.

Agendia Presents Data Supporting MammaPrint’s Predictive and Prognostic Power at 2009 St. Gallen Breast Cancer Conference

HUNTINGTON BEACH, California, and AMSTERDAM, The Netherlands - Agendia, a world leader in molecular cancer diagnostics, today
announced that leading researchers from Agendia and the Netherlands Cancer
Institute will present data from multiple studies at the 2009 St.Gallen
Breast Cancer Conference. The St. Gallen Breast Cancer Conference, one of the
premiere conferences in breast cancer research worldwide, takes place March
11th-14th, 2009 in St.Gallen, Switzerland.

Simbionix Increases Product Offerings for OB/GYN Physicians

CLEVELAND and ZURICH, Switzerland - Simbionix and VirtaMed Have Joined Forces to Provide OB/GYN Surgeons
the Most Advanced Training System for Endoscopic Surgery

TriPollar(TM) POSE(TM) Introduces the Non-Invasive Home-Use Solution to a Sculpted Body

TEL AVIV - New Clinical Device for Body Generates Inch-Loss, Cellulite Reduction
and the Tightening of Lax Skin